FDA Issues Recommendations for the Development of Individualized Therapies for Patients With Ultra-Rare Diseases
Key Takeaway: The FDA is developing a “plausible mechanism framework” to facilitate approval of individualized therapies for the treatment of rare genetic diseases that currently face approval challenges. As discussed previously...
USPTO’s Supplemental Guidance on Design Patents for Computer-Generated Interfaces and Icons
Key Takeaway: The USPTO has revised its design patent guidance to better reflect evolving digital interface technologies, including projections and augmented or virtual reality environments. The updated guidance provides design...
Tom Cowan Discusses IP Issues Relevant to “Dual-Use” Aerospace Technologies on The Space Hour Podcast
In a recent episode of The Space Hour podcast, Knobbe Martens partner Tom Cowan offered insights on the unique intellectual property (IP) challenges facing “dual-use” aerospace companies – those technology...
Subscribe for News and Updates
